Shares of RHC have been edging higher as investors respond favorably to their recent AGM on Tuesday.
With respect to their Capio AB acquisition, management continues to target overall positive core growth of up to 2% in FY 2019.
You're not a member! Trial today
With the share price at 22X present earnings, we would have liked to seen a higher rate of expected core growth to sustain a rally from current levels.
RHC remains under an ALGO sell signal but we expect the $51.00 level to show solid support and an ALGO buy signal in the medium-term.
Ramsay Health
